Exagen Inc. (NASDAQ: XGN) Stock Information | RedChip

Exagen Inc. (NASDAQ: XGN)


$4.2500
+0.3300 ( +7.60% ) 62.3K

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Market Data


Open


$4.2500

Previous close


$3.9200

Volume


62.3K

Market cap


$73.68M

Day range


$3.7120 - $4.3100

52 week range


$1.3003 - $4.8300

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 19, 2024
4 Insider transactions 1 Nov 18, 2024
10-q Quarterly Reports 60 Nov 12, 2024
8-k 8K-related 15 Nov 12, 2024
4 Insider transactions 1 Sep 04, 2024
3 Insider transactions 1 Sep 04, 2024
8-k 8K-related 15 Aug 05, 2024
10-q Quarterly Reports 60 Aug 05, 2024
8-k 8K-related 17 Aug 02, 2024
8-k/a 8K-related 13 Aug 02, 2024

Latest News